{
  "id": "70693dca169006c5",
  "title": "FDA Clears Abbott Volt PFA System For AFib , Expanding US Treatment Options - Abbott Laboratories ( NYSE : ABT ) ",
  "description": "20251222T210000Z",
  "content": "",
  "source": "benzinga.com",
  "source_url": "https://www.benzinga.com/news/fda/25/12/49544089/fda-clears-abbotts-volt-pfa-system-for-afib-expanding-us-treatment-options",
  "published_at": "20251222T210000Z",
  "fetched_at": "2025-12-23T00:22:44.609575+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.benzinga.com/news/fda/25/12/49544089/fda-clears-abbotts-volt-pfa-system-for-afib-expanding-us-treatment-options",
    "url_mobile": "",
    "title": "FDA Clears Abbott Volt PFA System For AFib , Expanding US Treatment Options - Abbott Laboratories ( NYSE : ABT ) ",
    "seendate": "20251222T210000Z",
    "socialimage": "https://cdn.benzinga.com/files/images/story/2025/12/22/Abbott-Laboratories.jpeg?&fit=crop",
    "domain": "benzinga.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}